Company: 908 Devices
Job title: Director of Business Development & Strategy, Life Sciences
Glenn has worked at 908 Devices Inc. since 2012 helping to commercialize the high-pressure mass spectrometry (HPMS) platform. Currently, he directs the business development and strategy of the life science platforms. Prior to joining 908 Devices, Glenn received his PhD in Analytical Chemistry from the Georgia Institute of Technology and had a post-doctoral fellowship at the Vanderbilt University Medical Center.
Improved cell media quality control and optimization with at-line analytics from the REBEL 1:00 pm
There is a need for advanced process analytical technologies to monitor lot-to-lot media quality and essential bioreactor nutrients and cellular metabolites alongside bioreactors. – Discussed here is a benchtop analyzer called the REBEL. The REBEL enables wide (32 analytes) and rapid (<10 mins) analysis of cell media with just ten microliters of sample to expedite…Read more
day: Day One